Key facts
- This page summarizes Barbara Weber's Form 4/A filing for Revolution Medicines, Inc. (RVMD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Jun 2024, 17:07.
Barbara Weber - 20 Jun 2024 Form 4/A Insider Report for Revolution Medicines, Inc. (RVMD)
- Reporting relationship
- Director
- Issuer ticker
- RVMD
- Reported as of
- 20 Jun 2024
- Net transaction value
- $0
- SEC form
- 4/A
- Accepted by SEC
- 28 Jun 2024, 17:07:50 UTC
- Original report date
- 24 Jun 2024
- Prior SEC filing
- 08 Feb 2024
- Next SEC filing
- 23 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jack Anders, as Attorney-in-fact for Barbara Weber
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Barbara Weber filed Form 4/A for Revolution Medicines, Inc. (RVMD) on 28 Jun 2024.
Change
- Previous filing in this sequence was filed on 08 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RVMD
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,248
- Change %
- +27%
- Price
- $0.000000
- Shares after
- 20,073
- Date
- 20 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RVMD
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +15,955
- Change %
- Price
- $0.000000
- Shares after
- 15,955
- Date
- 20 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,955
- Exercise price
- $37.54
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 4,248 restricted stock units ("RSUs").
Footnote F2
Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date.
SEC remarks
On June 24, 2024, the Reporting Person filed a Form 4 that inadvertently reported incorrect amounts for the RSU and Stock Option awards granted to the Reporting Person on June 20, 2024. The correct amounts and footnote information are reflected in this amendment.